Eliglustat Tartrate

酒石酸艾格司他

Report date: 2022/11/14 11:36:58
NME

Base Information

Drug NameEliglustat Tartrate
Drug Alias Name依利格鲁eliglustateliglustatum依利格鲁司他依鲁司他 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCeramide glucosyltransferase inhibitors
TargetsCeramide glucosyltransferase
Therapy Area/IndicationsGaucher's disease type IGaucher Disease
Global Approved IndicationsGaucher Disease
Approved Indications in ChinaGaucher Disease
Original Approved Country/TerritoryUnited States
Original Approved Date2014/08/19
Country/TerritoryBulgariaCanadaUnited States +[30] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesSanofiGenzyme CorpBeijing Gloria Tiancheng Pharmaceutical Technology Co Ltd +[4] 
Inactive CompaniesWellspring Pharmaceutical Canada CorpGenzyme (Shanghai) Biopharmaceutical Service Co Ltd
Active IndicationsGaucher Disease
Inactive IndicationsGaucher's disease type I

Other Information

ATC CodeA16AX10
Related LinksWikipediaDrugBankKEGG